Conexeu Sciences Inc.
PublicConexeu Sciences Inc. is now publicly traded
The data on this page reflects Conexeu Sciences Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Seed Round
Sep 15, 2026
Total Funding Raised
$6.7M
Company Overview
Conexeu Sciences Inc. is a biotechnology company that develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics, wound care, and tissue engineering.
AI Layer
Non-AI
Keywords
Conexeu Sciences Inc. Comparables
Compare Conexeu Sciences Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RegenX Science | 79% | |
| LifeSprout | 77% | |
| GenAssist, Inc. | 75% |
Conexeu Sciences Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Sep 15, 2026 | ||||
| Private Placement | Jul 31, 2026 | ||||
| Seed Round | May 21, 2026 | ||||
| Seed Round | May 21, 2026 | ||||
| Seed Round | Feb 27, 2026 | ||||
Crowdfunding | Oct 16, 2025 |
Key People
Founding team and executive leadership
Conexeu Sciences Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Equifund | Crowdfunding |
| UBC Investment Management | Seed |
Recent news
Latest coverage and updates
- is_developingAug 13, 2026
Conexeu Sciences Inc. is developing CXU platform on Aug 14th '26.
- expands_facilitiesJun 25, 2026
Conexeu Sciences Inc. expanded facilities to Vancouver, Canada, Northern America, Americas on Jun 23rd '26.
Conexeu Sciences Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access